Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Therapeutic Innovation & Regulatory Science|September 21, 2018
Adaptive Clinical Trials: Overview of Phase III Designs and ChallengesJeff Maca, Vladimir Dragalin, Paul GalloJournal of Biopharmaceutical Statistics|May 27, 2006
Adaptive designs in clinical drug development--an Executive Summary of the PhRMA Working GroupPaul Gallo, Christy Chuang-Stein, Vladimir Dragalin, et al.Statistics in Medicine|January 22, 2026
Informative Futility Rules Based on Conditional AssuranceVladimir DragalinEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 5, 2010
An introduction to adaptive designs and adaptation in CNS trialsVladimir DragalinJournal of Biopharmaceutical Statistics|November 9, 2010
Viewpoints on the FDA draft adaptive designs guidance from the PhRMA working groupPaul Gallo, Keaven Anderson, Christy Chuang-Stein, et al.Pharmaceutical Statistics|April 17, 2007
Implementation of an adaptive group sequential design in a bioequivalence studyNibedita Bandyopadhyay, Vladimir DragalinStatistics in Medicine|October 28, 2005
Design of multi-centre trials with binary responseVladimir Dragalin, Valerii FedorovJournal of Biopharmaceutical Statistics|November 21, 2007
Adaptive designs in clinical drug development: opportunities, challenges, and scope reflections following PhRMA's November 2006 workshopMichael Krams, Carl-Fredrik Burman, Vladimir Dragalin, et al.Biometrical Journal. Biometrische Zeitschrift|October 5, 2010
Adaptive Dc-optimal designs for dose finding based on a continuous efficacy endpointS Krishna Padmanabhan, Vladimir DragalinBiometrical Journal. Biometrische Zeitschrift|September 7, 2010
Likelihood inference for a two-stage design with treatment selectionIonut Bebu, George Luta, Vladimir DragalinPageof 6